Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
08/2005
08/17/2005EP1562940A2 Aryl sulfonamides
08/17/2005EP1562925A1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
08/17/2005EP1562924A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
08/17/2005EP1562923A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
08/17/2005EP1562907A1 Pyridine derivatives as cb2 receptor modulators
08/17/2005EP1562906A2 Heterocyclic selective androgen receptor modulators and methods of use thereof
08/17/2005EP1562905A2 Methylene urea derivatives as raf-kinase inhibitors
08/17/2005EP1562904A1 Pyridine derivates useful as fragrance materials
08/17/2005EP1562903A2 Mucin synthesis inhibitors
08/17/2005EP1562902A1 2-pyridone derivatives as inhibitors of neutrophile elastase
08/17/2005EP1562895A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/17/2005EP1562595A1 Diaryl ethers as opioid receptor antagonists
08/17/2005EP1562574A1 2-oxo-ethanesulfonamide derivates
08/17/2005EP1280757B1 New gamma selective retinoids
08/17/2005EP1218344B1 Oxidation colorant starting products
08/17/2005EP1196397B1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
08/17/2005EP1087943B1 Therapeutic biaryl derivatives
08/17/2005CN1656195A Method for producing highly pure tris-ortho metalated organoiridium compounds
08/17/2005CN1656109A Non nucleoside reverse transcriptase inhibitors
08/17/2005CN1656077A Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors
08/17/2005CN1656074A Method for producing 4-haloalkyl nicotinic acid amides
08/17/2005CN1656073A Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
08/17/2005CN1656072A Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
08/17/2005CN1655783A Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative
08/17/2005CN1654459A Substituted aminosalicylic acid amides with fungicidal effect and intermediate products for production thereof
08/17/2005CN1654455A Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
08/17/2005CN1215055C Arylsulfonamido-substituted hydroxamic acid derivatives
08/17/2005CN1215054C Microbicidal N-sulfonylglycin alkynyloxyphenemethyl amide derivatives
08/16/2005US6930200 Mono-and di-substituted alpha-amino acid derivatives useful as raw materials for pharmaceutical and agro-chemical products
08/16/2005US6930131 Hetero or aromatic-alkyloxyalkylphenylsulfonamide or analogs or derivatives useful in treating metabolic disorders mediated by insulin resistance or hyperglycemia
08/16/2005US6930117 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
08/16/2005US6930113 For therapy and prophylaxis of sexual dysfunctios; hypertension, pulmonary hypertension, congestive heart failure, renal failure, myocardial infraction, stable, unstable and variant (Prinzmetal) angina, atherosclerosis
08/16/2005US6930106 Inhibitors of HCV NS5B polymerase
08/16/2005US6929872 Organic electroluminescent devices
08/16/2005US6929870 Hydrocarbon compounds, materials for organic electroluminescent elements and organic electroluminescent elements
08/11/2005WO2005073201A1 Urea derivatives
08/11/2005WO2005073193A1 Vanilloid receptor ligands and their use in treatments
08/11/2005WO2005073165A1 Amide derivatives, process for production of the same, and method for application thereof as insecticide
08/11/2005WO2005072733A1 Dyarylurea compounds as chk-1 inhibitors
08/11/2005WO2005072681A2 Vanilloid receptor ligands and their use in treatments of inflammatory and neurotic pain.
08/11/2005WO2005058840A3 Method of coloring with capped diazotized compound and coupling component
08/11/2005WO2005056510A3 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics
08/11/2005WO2005051914A8 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
08/11/2005WO2005051302A3 Bicyclic inhibitors of mek and methods of use thereof
08/11/2005WO2005034856A3 Targeted drug-formaldehyde conjugates and methods of making and using the same
08/11/2005WO2005023422A3 Production and use of ionic liquids containing thiocyanato anions
08/11/2005WO2005020897A3 Compositions and methods for the treatment of disease associated with trp-p8 expression
08/11/2005WO2005000233A3 Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders
08/11/2005WO2004110983A8 New benzamides as pparϒ modulators
08/11/2005WO2004014847A8 Mcp-1 receptor antagonists and method of use thereof
08/11/2005US20050176994 Simultaneously or continuously reacting a sulfuric ester alkylating agent, an aromatic hydrocarbon preferably containing an electron withdrawing group and an electron donating group, and a maleic anhydride derivative.
08/11/2005US20050176964 Nicotinamide derivatives useful as p38 inhibitors
08/11/2005US20050176958 Rhodium and iridium complexes
08/11/2005US20050176857 thermostable, light fastness, for making color filters for liquid crystal displays; substituted 2,6-bis(2-hydroxyethylamino)-3-(phenylazo)-pyridine compounds of given formula; dye can react with monomers which are polymerized to form dye-modified polyurethanes, epoxy resins, polyesters or polyamides e.g.
08/11/2005US20050176828 Polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; antiproliferative agents; inhibition of cellular polyamine synthesis, even in the presence of exogenously supplied spermidine to inhibit cell growth and proliferation
08/11/2005US20050176821 Meta-substituted phenylene sulphonamide derivatives
08/11/2005US20050176784 Malononitrile compounds and their use as pesticides
08/11/2005US20050176780 2,5-disubstituted 3-mercaptopentanoic acid
08/11/2005US20050176779 dioxodihydropyridine derivatives and certain methacrylic acid and furan derivative precursors thereof; use as tumor growth inhibitors and anti-cancer agents, antibiotics and/or antiviral agents
08/11/2005US20050176778 Isoprenyl derivatives and their use in the title treatment and prevention of osteoporosis and cardiovascular calcification
08/11/2005US20050176775 Substituted pyridinones
08/11/2005US20050176767 Pyridine carboxamide and methods for inhibiting HIV integrase
08/11/2005US20050176766 2,3-Oxidosqualene-lanosterol cyclase inhibitors
08/11/2005US20050176758 2-(hydroxy or methoxymethoxy)-4-(carboxy or alkoxycarbonyl)-5-(fluoro or hydrogen)-7-oxabicyclo(4.1.0)hept-3-ene chemical intermediates to neuraminidase inhibitors
08/11/2005US20050176734 Method for producing 4-haloalkyl nicotinic acid amides
08/11/2005US20050176733 Chk-1 inhibitors
08/11/2005US20050176727 Male erectile dysfunction; 1-(3-chlorophenyl)-3-(4-pyridin-2-yl-piperazin-1-yl)propan-1-one O-methyloxime
08/11/2005US20050176721 2,5-Diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylprimidines
08/11/2005US20050176719 An enzyme inhibitors of cyclin-dependent kinases, antitumor agents; chemical intermediate synthesis
08/11/2005US20050176713 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
08/11/2005US20050176706 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
08/11/2005US20050175867 Room-temperature molten salt, process for producing the same and applications thereof
08/11/2005US20050175860 Phenyl pyridine-iridium metal complex compounds for organic electroluminescent device and organic electroluminescent device using thereof
08/11/2005US20050172420 Based on diaminobenzanilides or, more specifically (aminobenzoylamino),(sulfo-),(methoxy)anilines; stable aqueous solutions;nonbleeding/colorfastness; excellent degrees of exhaustion with high colour strength; dyeing natural or synthetic materials, particularly, paper; neutral or greenish-yellow hues
08/11/2005DE102004001950A1 Verfahren zur Stabilisierung von 4-Halogenpyridinen A method for stabilizing 4-halopyridines
08/11/2005DE10138561B4 Tumorhemmende Cerverbindungen sowie deren Verwendung Tumor-inhibiting cerium compounds and their use
08/11/2005CA2554911A1 Urea derivatives
08/11/2005CA2553968A1 Vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain
08/10/2005EP1561749A1 TNF-Alpha production inhibitors for the treatment of autoimmune diseases
08/10/2005EP1561741A1 Method for deuteration or tritiation of heterocyclic ring
08/10/2005EP1561462A2 Anti arrhytmic composition and methods of treatment
08/10/2005EP1560827A1 Anti-infective agents
08/10/2005EP1560824A1 Compounds useful as inhibitors of jak and other protein kinases
08/10/2005EP1560810A1 Bifunctional phenyliso(thio)cyanates; method and intermediate products for the production thereof
08/10/2005EP1560584A2 Fab i inhibitors
08/10/2005EP1444195B1 Process for the preparation of alpha-hydroxycarboxylic acid amides
08/10/2005EP1395265A4 Combretastatin a-3 prodrug
08/10/2005EP1368433B1 Novel reactive dyes and the use thereof for dyeing substrates containing nucleophilic groups
08/10/2005EP1333794A4 Novel coupler for use in oxidative hair dyeing
08/10/2005EP1157002B1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
08/10/2005EP0968158B1 Method of preparing substituted indanones, the substituted indanones and metallocenes prepared therefrom
08/10/2005CN1653065A Improved method for making nevirapine
08/10/2005CN1653049A Pesticidal pyridinecarboxamide derivatives
08/10/2005CN1653048A Pyridine carboxamide derivatives and their use as pesticides
08/10/2005CN1653047A Monocyclic aroylpyridinones as antiinflammatory agents
08/10/2005CN1653042A Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
08/10/2005CN1653037A Substituted tetracycline compounds
08/10/2005CN1653030A Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative
08/10/2005CN1652803A Medicine for prevention of and treatment for amyloidosis
08/10/2005CN1652782A Nicotinamide derivatives useful as PDE4 inhibitors